Rethink Pink and Screening Mammography

“Mammography screening for breast cancer has significant drawbacks, and expected survival benefits have not materialized.” –Dr Laura Esserman.

A Closer Look at Screening Mammography

Dr Laura Esserman of the University of California startled the medical community with an article questioning screening mammography published in the Journal of the American Medical Association (JAMA ).   Dr Laura Esserman reviewed 20 years of breast cancer data.  Her conclusion is not favorable:

“Mammography screening for breast cancer has significant drawbacks, and expected survival benefits have not materialized. “

“While the incidence of early stage breast cancer has decreased due to mammography, the incidence rates for the killer cancers, (the advanced cancers) have remained stable.  While it is true that overall mortality rates have declined slightly, this is attributed to better treatment rather than increased detection.”  Dr Laura Esserman.

Source: Rethink Pink and Screening Mammography